Fulgent Genetics (MEX:FLGT) Earnings per Share (Diluted) : MXN-93.43 (TTM As of Jun. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Fulgent Genetics Earnings per Share (Diluted)?

Fulgent Genetics's Earnings per Share (Diluted) for the three months ended in Jun. 2024 was MXN-5.31. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was MXN-93.43.

Fulgent Genetics's EPS (Basic) for the three months ended in Jun. 2024 was MXN-5.31. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2024 was MXN-93.43.

Fulgent Genetics's EPS without NRI for the three months ended in Jun. 2024 was MXN-5.31. Its EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2024 was MXN-15.69.

During the past 10 years, Fulgent Genetics's highest 3-Year average EPS without NRI Growth Rate was 72.90% per year. The lowest was -21.50% per year. And the median was 7.40% per year.

Fulgent Genetics Earnings per Share (Diluted) Historical Data

The historical data trend for Fulgent Genetics's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fulgent Genetics Earnings per Share (Diluted) Chart

Fulgent Genetics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Earnings per Share (Diluted)

Get a 7-Day Free Trial

-0.38

177.24

336.02

90.27

-95.57

Fulgent Genetics Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Earnings per Share (Diluted)	Get a 7-Day Free Trial															-6.52	-7.66	-72.99	-7.47	-5.31

Competitive Comparison of Fulgent Genetics's Earnings per Share (Diluted)

For the Diagnostics & Research subindustry, Fulgent Genetics's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fulgent Genetics's PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Fulgent Genetics's PE Ratio distribution charts can be found below:

* The bar in red indicates where Fulgent Genetics's PE Ratio falls into.

Fulgent Genetics Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

Fulgent Genetics's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2023 is calculated as

Diluted Earnings Per Share (A: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(-2848.703	-	0)	/	29.784
	=	-95.65

Fulgent Genetics's Earnings Per Share (Diluted) for the quarter that ended in Jun. 2024 is calculated as

Diluted Earnings Per Share (Q: Jun. 2024 )	=	(Net Income	-	Preferred Dividends	/	Shares Outstanding (Diluted Average)
	=	(-159.568	-	0)	/	30.098
	=	-5.30

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN-93.43

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.

Fulgent Genetics (MEX:FLGT) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Fulgent Genetics Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of Fulgent Genetics's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.

Fulgent Genetics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Fulgent Genetics Inc (MEX:FLGT) » Definitions » Earnings per Share (Diluted)

Comparable Companies

Traded in Other Exchanges

FLGT:USA 7F0:Germany

Address

4978 Santa Anita Avenue, Temple City, CA, USA, 91780

Website

https://www.fulgentgenetics.com

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. Genetic testing offers the possibility of early identification of a disease or a genetic predisposition to disease and enhanced disease treatment and prognosis. Fulgent's product portfolio includes Genes & Panels, Known Mutation, Genomic Testing, Hereditary Cancer, Carrier Screening, Tumor Profiling, and Sequencing Service. Its customers are categorized as Insurance; Institutional, which includes hospitals, medical institutions, laboratories, governmental bodies, municipalities, and large corporations; and Patients. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.